SCHEMBL4789019

SCHEMBL4789019

COc1nc(NC(=O)c2ccc(Cl)cc2)c(C(=O)O)n1-c1ccc(F)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.41
KDM4E B2RXH2 2/20 0.41
ADCY1 Q08828 1/20 0.40
EGFR P00533 1/20 0.40
ERBB3 P21860 1/20 0.40
PARP15 Q460N3 1/20 0.40
TNKS2 Q9H2K2 1/20 0.40
PARP2 Q9UGN5 1/20 0.40
MAPT P10636 5/20 0.40
ALDH1A1 P00352 2/20 0.40
MAPK8 P45983 1/20 0.40
ABCG2 Q9UNQ0 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
UBE2N P61088 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
APAF1 O14727 1/20 0.39
MAPK1 P28482 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4885880 0.88 CNR1 (0.39) SMN1; SMN2KDM4EADCY1EGFRERBB3
SCHEMBL4788948 0.85 KMT2A (0.43) SMN1; SMN2MAPTALDH1A1MEN1KMT2A
SCHEMBL4891786 0.81 ALDH1A1 (0.42) SMN1; SMN2KDM4EMAPTALDH1A1MEN1
SCHEMBL4747643 0.80 FFAR2 (0.44) SMN1; SMN2MAPTALDH1A1L3MBTL1
SCHEMBL4786538 0.80 CXCR2 (0.45) SMN1; SMN2MEN1KMT2ACASP3SENP8
SCHEMBL4786438 0.75 CNR1 (0.43) MAPTALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL4749922 0.75 KDM4E (0.45) SMN1; SMN2KDM4EMAPTALDH1A1L3MBTL1
SCHEMBL4576546 0.73 PTGS2 (0.49) SMN1; SMN2ALDH1A1MEN1KMT2ANPC1
SCHEMBL4897158 0.72 MAPT (0.41) KDM4EMAPTALDH1A1
SCHEMBL4788013 0.72 ENPP2 (0.43) SMN1; SMN2MAPTALDH1A1MAPK1PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008130313-A1 IMIDAZOLE DERIVATIVES AS MODULATORS OF THE GABA RECEPTOR FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS ASTRAZENECA AB (SE) 2008-10-30 WO disclosed